© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, MediciNova, Inc. (MNOV) shows an Average True Range (ATR) of 0.06 and an Enterprise Value of 15.67M. Its average trading volume over the past 3 months is 872.29K, indicating liquidity. These fundamental metrics provide insight into MNOV's underlying financial health and market activity.
MediciNova, Inc. (MNOV) technical indicators as of December 22, 2025: the SMA 20 is -3.8%, SMA 50 at 1.61%, and SMA 200 at 4.31%. The RSI 14 value is 45.8, suggesting its current momentum. These technical analysis signals help assess MNOV's price trends and potential future movements.
MediciNova, Inc. (MNOV) stock performance overview as of December 22, 2025: The 52-week high is $2.2 (currently -36.06% below), and the 52-week low is $1.13 (currently 26.55% above). Over the past year, MNOV's performance is -31.9%, compared to the S&P 500's 12.87% change.
According to market data, MediciNova, Inc. (MNOV) stock's recent performance metrics show that over the last month, MNOV is -0.69%, with a Year-to-Date (YTD) performance of -31.9%. Over the past year, the stock has seen a -31.9% change. These figures summarize MNOV's price movements across various periods, reflecting its historical returns.
According to current financial data, MNOV stock's P/E (TTM) ratio is -5.94, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for MNOV, including P/S (521.01), P/B (1.50), and P/FCF (-0.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.